Search
for
Sort by
Research 151–180 of 455
- Psychotropic Treatment of Psychodermatologic Disorders
- Cytokines
- Scalp Tourniquets for Chemotherapy-Induced Alopecia
- Unravelling Beau's lines as a potential indicator of severe immune response in COVID-19 and reinfection
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Mitoxantrone, Etoposide and Prednisolone—a Novel Combination in The Treatment of Relapsed and Refractory Lymphoma
- Alopecia and Amphetamine Use-Reply
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- New therapies for alopecia areata
- Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT
- Current systemic treatment strategies for hidradenitis suppurativa
- New-onset systemic lupus erythematosus during pregnancy: A challenge in diagnosis
- Sub-acute Toxicosis Caused by a Multiple Doses Tegafur/Uracil (UFT) for Suicide: A Case Report
- Dermatological drugs, topical agents, and cosmetics
- Index of Suspicion
- Nurses' Drug Alert
- Cerebellar Medulloblastoma: Treatment by Irradiation of the Whole Central Nervous System
- Geriatric Dermatologic Therapy
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- A Rare Case of Antinuclear Antibody-Negative Systemic Lupus Erythematosus Presenting With Generalized Lymphadenopathy as the Initial Manifestation
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Evidence for the off-label use of tofacitinib in alopecia areata
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP